ArcelorMittal expands its portfolio of renewable energy projects

ArcelorMittal expands its portfolio of renewable energy projects GlobeNewswire December 22, 2025 Three new projects in India will bring the Company's global renewable energy capacity to 3.3GW 22 December 2025, 08:30 CET ArcelorMittal ('the Company') today announces three new renewable energy projects in India totaling 1GW of nominal solar and wind capacity. Upon completion the […]

A.P. Moller Capital announces Indian renewables investment with Rays Power Infra

A.P. Moller Capital, through the A.P. Moller Capital – Emerging Markets Infrastructure Fund II, invest in India through a newly established renewables development business Joint venture with Rays Power Infra will accelerate delivery of utility-scale renewable capacity across India Initial projects already under development totaling 900 MW COPENHAGEN, Denmark, Dec. 22, 2025 (GLOBE NEWSWIRE) —

Alvotech announces European launch of first-in-market biosimilar to Simponi(R) (golimumab) globally by partner Advanz Pharma

(NasdaqGM:ALVO),(Nasdaq First North Iceland:ALVO),(Stockholm:ALVO SDB), Introduction of AVT05 supported by NHS England tender award in the United Kingdom REYKJAVIK, Iceland, Dec. 22, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that launches are underway in Europe for Gobivaz(R)

A.P. Moller Capital announces Indian renewables investment with Rays Power Infra

A.P. Moller Capital announces Indian renewables investment with Rays Power Infra GlobeNewswire December 22, 2025 A.P. Moller Capital, through the A.P. Moller Capital – Emerging Markets Infrastructure Fund II, invest in India through a newly established renewables development business Joint venture with Rays Power Infra will accelerate delivery of utility-scale renewable capacity across India Initial

Alvotech announces European launch of first-in-market biosimilar to Simponi(R) (golimumab) globally by partner Advanz Pharma

Alvotech announces European launch of first-in-market biosimilar to Simponi(R) (golimumab) globally by partner Advanz Pharma GlobeNewswire December 22, 2025 Introduction of AVT05 supported by NHS England tender award in the United Kingdom REYKJAVIK, Iceland, Dec. 22, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar

THEON concludes a transformative 2025

(Euronext Amsterdam:THEON), THEON concludes a transformative 2025 Materially broadened and enhanced strategic platform, total backlog and options of c.EUR2.4 bn, secured supply chain, and high confidence in (unchanged) profitability guidance Bloomberg (THEON:NA) / Reuters (THEON.AS) 22 December 2025 – Theon International Plc (THEON) today provides a review of its strategic, operational and financial progress during

THEON concludes a transformative 2025

THEON concludes a transformative 2025 GlobeNewswire December 22, 2025 THEON concludes a transformative 2025 Materially broadened and enhanced strategic platform, total backlog and options of c.EUR2.4 bn, secured supply chain, and high confidence in (unchanged) profitability guidance Bloomberg (THEON:NA) / Reuters (THEON.AS) 22 December 2025 – Theon International Plc (THEON) today provides a review of

Trends in Plant-Based Food Bioplastics Market 2025-35

Trends in Plant-Based Food Bioplastics Market 2025-35 As reported by Towards Packaging experts, the global plant-based food bioplastics market is anticipated to rise from USD 1.22 billion in 2026 to approximately USD 1.90 billion by 2034, with a CAGR of 5.7% from 2025 to 2034. GlobeNewswire December 22, 2025 Ottawa, Dec. 22, 2025 (GLOBE NEWSWIRE)

WISeKey Issues Year-End CEO Letter to Shareholders

(SWX:WIHN),(NASDAQ:WKEY), Geneva, Switzerland, December 22, 2025 – WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, today issued a Letter to Shareholders by its Founder and CEO, Carlos Moreira. Dear Shareholders, As we close 2025, I would like to take a moment to reflect on what has

AMG Lithium Receives Funding from German Federal Ministry for Economic Affairs and Energy

(Euronext Amsterdam:AMG), Amsterdam, 22 December 2025 — AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) subsidiary AMG Lithium GmbH (“AMG Lithium”) is in the qualification phase before full commercial production at its lithium hydroxide refinery in Bitterfeld, Germany. After having completed ongoing customer testing of factory samples, the site will be the first industrial-scale battery-grade

Scroll to Top